Insitro’s $400 Million Series C Financing Round

Debevoise & Plimpton LLP is advising Canada Pension Plan Investment Board (CPP Investments) as the lead investor in the transaction.

insitro completed its $400 million Series C financing.

CPP Investments is a professional investment management organization that invests around the world in the best interests of the more than 20 million contributors and beneficiaries of the Canada Pension Plan.

insitro is a machine learning-driven drug discovery and development company.

The Debevoise team was led by M&A partner Kevin Schmidt (Picture) and included counsel David Iozzi and associates Kim Le, Melissa Runsten and Milan Udawatta, benefits associate Matthew Trudeau, tax associate Gregory Arutiunov, capital markets associate Benjamin Pedersen, data strategy and security partner Luke Dembosky, intellectual property associate Paisley Piasecki, antitrust counsel Kyra Bromley, FDA regulatory partner Paul Rubin and regulatory partner Andrew Levine and associate Sarah Wolf.

Involved fees earner: Gregory Arutiunov – Debevoise & Plimpton; Kyra Bromley – Debevoise & Plimpton; Luke Dembosky – Debevoise & Plimpton; David Iozzi – Debevoise & Plimpton; Kim Le – Debevoise & Plimpton; Andrew Levine – Debevoise & Plimpton; Benjamin Pedersen – Debevoise & Plimpton; Paul Rubin – Debevoise & Plimpton; Melissa Runsten – Debevoise & Plimpton; Kevin Schmidt – Debevoise & Plimpton; Milan Udawatta – Debevoise & Plimpton; Sarah Wolf – Debevoise & Plimpton;

Law Firms: Debevoise & Plimpton;

Clients: Canada Pension Plan Investment Board;

Author: Martina Bellini